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ABSTRACT  
PEX5 is the shuttling receptor for newly synthesized peroxisomal matrix proteins. Alone, or with the 
help of an adaptor protein, this receptor binds peroxisomal matrix proteins in the cytosol and 
transports them to the peroxisomal membrane docking/translocation module (DTM). The 
interaction between cargo-loaded PEX5 and the DTM ultimately results in its insertion into the DTM 
with the concomitant translocation of the cargo protein across the organelle membrane. PEX5 is 
not consumed in this event; rather it is dislocated back into the cytosol so that it can promote 
additional rounds of protein transportation. Remarkably, the data collected in recent years indicate 
that dislocation is preceded by monoubiquitination of PEX5 at a conserved cysteine residue. This 
mandatory modification is not the only type of ubiquitination occurring at the DTM. Indeed, several 
findings suggest that defective receptors jamming the DTM are polyubiquitinated and targeted to 
the proteasome for degradation. 
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INTRODUCTION  
Covalent attachment of ubiquitin (Ub) to a protein substrate requires an enzymatic cascade 
comprising three components: 1) an ATP-dependent ubiquitin-activating enzyme (E1); 2) an 
ubiquitin-conjugating enzyme (E2); and 3) an ubiquitin ligase (E3). For many years this post-
translational modification was best known as a signal leading to protein degradation at the 
proteasome [1]. Presently, however, it is clear that ubiquitination is also used in a reversible manner 
to regulate almost all biological pathways in eukaryotic cells [2-4]. This reversibility is ensured by 
the action of deubiquitinating enzymes (DUBs), a group of proteases that specifically remove the 
ubiquitin moieties from the modified proteins [5]. The generalized use and complexity of 
ubiquitination/deubiquitination strategies in the spatiotemporal regulation of biological processes 
can be easily appreciated by considering just two properties of ubiquitin biology. The first is the 
overwhelming number of genes encoding proteins dedicated to ubiquitin conjugation/ 
deconjugation that can be found in any eukaryotic organism (mammals have 2 E1s, 40 E2s, more 
than 600 E3s and approximately 100 DUBs) [6]. The second is that ubiquitination can take many 
different forms. Indeed, proteins can be modified with a single ubiquitin (monoubiquitination), two 
or more ubiquitin molecules, each attached to a different amino acid residue (multi-ubiquitination), 
or with an ubiquitin chain (polyubiquitination). In the latter case, the complexity is further increased 
because different E2/E3 pairs can build polyubiquitin chains with different topologies. The final 
outcome of each of these modifications is not the same because the effectors that ultimately 
recognize and decode these ubiquitin signals are also different [7]. This review focuses on the 
mechanism of protein sorting into the peroxisome matrix, a biological pathway providing a 
remarkable example of how ubiquitination is used not just as part of a quality control process but 
also as one of its intrinsic steps. 
An overview on the peroxisomal import machinery (PIM) 
Peroxisomal matrix proteins are synthesized on cytosolic ribosomes and post-translationally 
targeted to the peroxisome via one of two peroxisome targeting signals (PTS) [8]. The majority of 
them possess a PTS type 1 (PTS1) at their C termini, a conserved tripeptide, usually with the 
sequence S-K-L [9,10]. Some peroxisome matrix proteins contain instead a PTS2. This is an N-
terminal degenerated nonapeptide with the sequence (R/K)-(L/V/I)-X5-(H/ Q)-(L/A), which in higher 
eukaryotes is cleaved upon import [11e 14]. In mammals, plants and many other organisms both 
PTS1 and PTS2 proteins are transported to the peroxisome by PEX5, the peroxisomal shuttling 
receptor [15-19]. PEX5 is a monomeric 70- kDa protein rich in intrinsically disordered domains [20-
22]. The interaction of PEX5 with PTS1 proteins is mediated by the PTS1 on one side and a PEX5 
domain containing seven tetratricopeptide repeats (TPRs) on the other, but other regions of the 
cargo protein and other domains of PEX5 also contribute to the interaction [23-27]. The PTS2-PEX5 
interaction, on the other hand, requires the adaptor protein PEX7 [15,17-19]. The situation in yeasts 
and fungi is slightly different because their PEX5 proteins lack a PEX7- interacting domain. In these 
organisms, PTS2 proteins are instead transported to the peroxisome by a protein complex 
comprising PEX7 and a species-specific peroxin that displays structural/functional similarities to the 
N-terminal half of mammalian PEX5 [12,28,29]. These species-specific peroxins (i.e., PEX18, PEX20 
and PEX21; see Table 1) are here referred to as PEX5-related proteins. Following cargo recognition 
in the cytosol, PEX5 interacts with the docking/translocation module (DTM), a multisubunit protein 
complex of the peroxisomal membrane comprising the core components PEX2, PEX10, PEX12, 
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PEX13 and PEX14 (see Table 1) [30-32]. This interaction ultimately results in the insertion of PEX5 
into the DTM with PEX5 adopting a transmembrane topology [33,34]. The presently available data 
suggest that cargo translocation across the peroxisomal membrane is coupled to the insertion of 
the receptor into the DTM ([35,36] and unpublished results). Remarkably, none of these steps 
requires ATP hydrolysis, a finding that led to the proposal that the driving force for the cargo 
translocation step resides in the strong, essentially irreversible, interactions that PEX5 establishes 
with components of the DTM [37-40]. Upon release of its cargo, DTM-embedded PEX5 has to be 
exported to the cytosol so that it can promote additional rounds of protein transportation. Many of 
the details of this process have been uncovered in recent years. First, PEX5 is monoubiquitinated in 
an unconventional manner [41,42]. Then, this monoubiquitinated PEX5 species (Ub-PEX5) is 
extracted from the DTM in an ATP-dependent manner by the receptor export module (REM) 
[40,41,43]. This is a protein complex comprising the two AAA ATPases, PEX1 and PEX6, and their 
membrane anchor PEX26 (or PEX15 and APEM9 in Saccharomyces cerevisiae and plants, 
respectively; see Table 1) [44-47]. Finally, the ubiquitin moiety is removed from Ub-PEX5 probably 
by a combination of enzymatic and non-enzymatic mechanisms thus resetting the protein transport 
system [48-50]. Monoubiquitination of PEX5 or PEX5-related peroxins is not the only type of 
ubiquitination occurring at the DTM. Indeed, a number of studies have revealed that these 
receptors are also targets of polyubiquitination, a modification that probably reflects the existence 
of a quality control system [51-54]. The properties of both types of ubiquitination occurring at the 
DTM are described below. 
Peroxisomes and the ubiquitin-proteasome system 
Although mammalian PEX2, a RING finger peroxin and a core component of the DTM, was one of 
the first proteins involved in peroxisome biogenesis to be identified [55-57], the link between RING 
proteins and E3s was not known at the time [58], and, therefore, the connection between 
peroxisome biogenesis and the ubiquitin pathway was not immediately perceived. The first data 
pointing to this connection came from the identification of a yeast peroxin, PEX4. Primary structure 
analysis of this protein revealed an obvious homology with ubiquitin E2s and, indeed, mutation of 
its catalytic cysteine was sufficient to block peroxisome biogenesis in yeast [59]. Further 
characterization of PEX4 revealed that this E2 is anchored to the peroxisomal membrane via PEX22, 
an intrinsic membrane protein. In the absence of PEX22, PEX4 becomes unstable indicating that the 
two proteins comprise a functional/structural unit [60]. Strikingly, all attempts to identify the 
mammalian PEX4 and PEX22 counterparts using either genomic or proteomic approaches failed 
[61e66] (but see Section 4). Interestingly, the steady-state levels of PEX5 and PEX20 in Pichia 
pastoris strains lacking PEX4 were found to be heavily decreased [53,60,67], a phenomenon that 
could be reversed by the simultaneous deletion of any of a group of genes encoding components of 
the DTM [67]. In strains lacking components of the REM the steady-state levels of both receptors 
were also diminished [53,67]. Apparently, a blockade at late steps of the import pathway induces 
the degradation of the shuttling receptors. Although no such phenomenon is observed in S. 
cerevisiae, it was shown that a fraction of PEX5 found in mutant strains lacking PEX4, PEX1 or PEX6 
is ubiquitinated, a process involving the cytosolic E2s Ubc1, Ubc4 and Ubc5 [51,52,54,60]. 
Altogether these data led to the proposal that there is an ubiquitin-based quality control system 
acting on receptors at the DTM that can no longer return to the cytosol using the normal 
mechanism (see Fig. 1 and following section). 
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Ubiquitination as an intrinsic step of the peroxisomal import pathway 
The data described above implicated PEX4 as an important player of the PIM, but did not unveil its 
mechanistic role. Research on this issue turned out to reveal one of the most interesting aspects of 
the PIM. The first hints on the function of PEX4 emerged from bio-informatic analyses proposing 
that the PIM and the Endoplasmic Reticulum-associated degradation (ERAD) machinery display 
structural/functional similarities [68,69]. In particular, those studies postulated that the role of PEX4 
in the PIM should be similar to the one of Ubc1/Ubc6/Ubc7 in the ERAD system, namely, the 
ubiquitination of a membrane-associated substrate so that it can be recognized and dislocated into 
the cytosol by AAA ATPases. The substrate in the ERAD system is a misfolded protein en route to 
the proteasome whereas in the PIM the substrate should be DTM-embedded PEX5 or PEX5-related 
proteins. Indeed, subsequent work using yeast and a mammalian peroxisomal in vitro import 
system provided the experimental evidence to support this hypothesis. Collectively, these studies 
showed that: 1) yeast PEX4 monoubiquitinates PEX5 at a conserved cysteine residue [42]; 2) 
mammalian DTM-embedded PEX5 is also monoubiquitinated at the conserved cysteine [41]; and 3) 
monoubiquitination of yeast and mammalian PEX5 at the DTM is a mandatory step for their 
subsequent export into the cytosol, a process catalyzed by the ATP-dependent REM [41,43]. These 
findings also provided the explanation for earlier reports showing that deletion of a small N-
terminal domain containing the conserved cysteine residue of human PEX5, or mutation of this 
cysteine in both P. pastoris PEX20 and human PEX5, resulted in proteins that could still enter the 
DTM but that were no longer substrates for the REM [38,70,71]. Recently, direct evidence showing 
that S. cerevisiae PEX18 and P. pastoris PEX20 are indeed modified by this type of unconventional 
ubiquitination was provided [72,73]. The finding that mammalian and yeast PEX5 are both 
monoubiquitinated at the DTM was unexpected at the time because, as stated above, mammals 
lack PEX4 and PEX22. On one hand, it was now obvious that the PIM of yeasts and mammals 
operate using similar principles, despite significant differences in their protein composition (see 
Table 1) [30-32]. On the other hand, it was evident that we were still missing components of the 
mammalian PIM. Using a peroxisome-dependent PEX5 monoubiquitination assay it was found that 
the long-sought mammalian E2 activity cofractionated with cytosolic proteins [74]. Actually, a 
simple low speed centrifugation of a post-nuclear supernatant was sufficient to separate the E2 
activity involved in this unconventional ubiquitination from peroxisomes, indicating that contrary to 
the situation in yeasts/fungi and probably also plants [59,60,66,75], the mammalian E2 enzyme is 
not stably bound to the peroxisomal membrane. Standard protein purification procedures followed 
by mass spectrometry led to its identification. Interestingly, not one but rather three different E2s 
were found in that study. These are the almost identical E2D1, E2D2 and E2D3 (also known as 
UbcH5a, b and c in humans), a group of multipurpose cytosolic E2 enzymes involved in numerous 
biological pathways [76,77]. Three of the five core components of the DTM have Zn
2+
-binding 
domains. These are PEX2, PEX10 and PEX12, a trio of proteins generally referred to as the “RING 
peroxins”. However, it must be noted that the typical sequence motif that characterize RING 
domains is found only in PEX10 from all organisms. Most PEX2 proteins also have this motif but 
there are some notorious exceptions (e.g., S. cerevisiae) [78,79], whereas all PEX12 proteins are 
completely atypical, lacking several of the eight conserved Zn
2+
-binding residues found in RING 
domains. Indeed, the corresponding domain of S. cerevisiae PEX12 was recently shown to bind only 
one Zn
2+
 [78]. Considering that RING domains define the largst class of E3 ubiquitin ligases, it was 
evident from the very first findings on receptor ubiquitination that the RING peroxins must have a 
role in these modifications. In agreement with this idea, it has been reported that the Zn
2+
-binding 
domains alone have E3 activity in in vitro ubiquitination assays [79-81]. Interestingly, although the 
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Zn
2+
-binding domains of all these proteins are exposed into the cytosol, monoubiquitination of 
PEX5 and PEX5- related proteins occurs only when these receptors are already embedded in the 
DTM. On the other hand, insertion of PEX5 into the DTM is not dependent on these peroxins 
[16,30,67,82]. Thus, the DTM resembles multi-subunit E3 ligases, in which substrates are recruited 
not by the RING proteins themselves but rather by other subunits of the protein complex (see Ref. 
[39]). Which of the three RING peroxins of the DTM (if any alone) mediates the unconventional 
ubiquitination of PEX5 remains unknown. We note that some attempts to address this issue using 
recombinant peroxin Zn
2+
-binding domains and PEX5 in in vitro ubiquitination assays have been 
reported [81]. However, no evidence for bona fide monoubiquitinated PEX5 was found so far. An 
interesting property of the RING peroxins is that the absence of any of these proteins leads to the 
instability of the other two [30,83,84]. This phenomenon suggests that the three proteins comprise 
a structural unit within the DTM, as is in fact supported by protein purification studies in yeast [30]. 
Interestingly, recent data suggest that the three RING peroxins may also display a functional 
interdependence. Indeed, disruption of the RING domain of any of these peroxins leads to a 
complete loss of both mono- and polyubiquitination of P. pastoris PEX20 [73]. These important 
findings suggest that all RING peroxins en bloc are required for both types of receptor 
ubiquitination and raise the appealing possibility that the RING peroxins may be simply modules of 
a single multi-Zn
2+
-binding domain ubiquitin ligase. An example of this type of architecture is 
provided by the RING-in-between-RING(IBR)-RING (RBR) family of ubiquitin ligases, a class of E3s 
that use a Homologous to E6-AP C terminus (HECT) E3-like mechanism to ubiquitinate a substrate. 
The catalytic regions of RBR E3s comprise three closely spaced domains: a canonical RING domain 
(RING1) which serves as the binding platform for the ubiquitin-loaded E2; a Zn
2+
-binding domain 
(the so-called IBR) which probably has a structural/regulatory role; and another Zn
2+
-binding 
domain, originally named the RING2 domain, which contains the catalytic cysteine [85]. RBR E3 
ligases, therefore, provide a remarkable example of how multiple Zn
2+
-binding domains can be 
structurally and functionally organized to perform a single function. Considering the P. pastoris 
data referred to above, it is tempting to speculate that a similar, although not necessarily identical, 
situation will be found for the RING peroxins. 
Receptor dislocation and deubiquitination 
According to current models (see Fig. 1 and Refs. [39,86e88]), there are at least four steps occurring 
during the transient passage of PEX5 through the peroxisomal DTM before its export into the 
cytosol: 1) docking; 2) insertion into the DTM/cargo protein translocation; 3) cargo release into the 
peroxisome matrix; and 4) monoubiquitination. In principle, monoubiquitination of PEX5 could 
coincide in time with any of the other three steps and even modulate/trigger one of them as was in 
fact previously proposed for the cargo release step [42]. However, several findings obtained with an 
in vitro peroxisomal import system suggest that this is not the case. Indeed, in the absence of an 
operating ubiquitin-conjugation cascade PEX5 can still enter the DTM where it acquires the 
expected transmembrane topology [40,41]; the same is true for PEX5 mutant proteins lacking the 
conserved cysteine residue [41,70]. Likewise, PEX5-mediated peroxisomal import of pre-thiolase, a 
PTS2 protein, and its processing in the peroxisomal matrix are also not affected when the ubiquitin-
conjugating cascade is blocked, a conclusion that we have recently extended also to PTS1 proteins 
([35] and unpublished observations). Thus, docking, insertion and cargo release do not depend on 
monoubiquitination of PEX5. These observations strongly suggest that monoubiquitination of PEX5 
is required for nothing else other than its export into the cytosol, a step catalyzed by the AAA 
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ATPases of the REM, PEX1 and PEX6. The mechanistic details of how monoubiquitinated PEX5 and 
PEX5-related proteins are recognized by the REM are not entirely understood. In principle, the REM 
could interact directly with DTM-embedded monoubiquitinated receptors. Alternatively, the 
recognition event might be mediated by an ubiquitin-binding adaptor protein. Some data 
supporting this last possibility was recently reported [89]. Using an in vitro import/export system, 
the authors noticed that export of peroxisomal PEX5 could be stimulated by adding back cytosolic 
proteins to the organelle fraction. Purification of this cytosolic activity led to the identification of 
AWP1, an ubiquitin-binding protein previously shown to interact with a member of the protein 
kinase C family [90] and to be a regulator of the NF-kB signaling pathway [91,92]. Protein-protein 
interaction studies led the authors to conclude that AWP1 mediates the interaction of Ub-PEX5 
with the REM thus explaining its stimulatory effect on PEX5 export. Dislocation of DTM-embedded 
Ub-PEX5 back into the cytosol is followed by its deubiquitination. This step is probably very fast in 
vivo because dithiothreitol-sensitive Ub-PEX5 species can only be detected in organelle fractions 
[42,49,93]. The DUBs acting on Ub-PEX5 have been recently identified in both yeast (UBP15) and 
mammals (USP9X) [48,50]. Interestingly, knock-out and knockdown of UBP15 and USP9X genes, 
respectively, do not lead to an accumulation of Ub-PEX5 in the cytosol, as would be expected if 
these enzymes were the only mean to remove ubiquitin from PEX5. Clearly, there are alternative 
ways to deubiquitinate PEX5, which may or may not include other less active/redundant DUBs. 
Indeed, as proposed recently deubiquitination of PEX5 does not have to necessarily involve a DUB 
[49]. This is due to the fact that the thioester bond linking ubiquitin to PEX5 is quite labile in the 
presence of physiologically relevant concentrations of glutathione, displaying a half-life of just 2.3 
min. Interestingly, DTM-embedded Ub-PEX5 is resistant to this trans-thiolation reaction suggesting 
that such non-enzymatic deubiquitinating mechanism would not create a futile 
ubiquitination/deubiquitination cycle at the DTM. Deubiquitination of PEX5 completes the PEX5-
mediated protein import cycle. 
Concluding Remarks 
Our understanding on the PEX5-mediated protein import pathway has increased dramatically in the 
last decade. The field has clearly moved into the functional/structural characterization of this 
machinery and we now have at least some ideas, as faint as they may be, on the role played by all 
components of the PIM. The challenge now is to understand its mechanistic details. Particularly 
puzzling in the PIM/ubiquitin topic is the fact that monoubiquitination of PEX5 and PEX5-related 
receptors occurs at a cysteine residue. This would be the expected situation if these receptors were 
E3-like proteins such as the members of the HECT and RBR E3 family [94]. However, this is clearly 
not the case: substitution of the conserved cysteine by a lysine (the classical target of 
ubiquitination) results in a PEX5 protein displaying seemingly normal import/export activities both 
in in vitro and in vivo assays [49]. We do know that, in contrast to quality control polyubiquitination, 
unconventional ubiquitination of receptors occurs at each protein import cycle, meaning that each 
receptor molecule is probably subjected to hundreds/thousands of 
monoubiquitination/deubiquitination cycles during its life time. Maybe this property holds the 
answer to the cysteine enigma. The thiol group of a cysteine residue is a much stronger nucleophile 
and a better leaving group than the 3-amino group of a lysine. The first property means that 
ubiquitination at a cysteine residue has the potential to occur at a larger rate than the classical 
lysine-targeted ubiquitination. This would imply that by using unconventional monoubiquitination 
of its receptors the PIM could support larger protein import fluxes. We note that previous attempts 
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aiming at detecting a difference between the monoubiquitination rates of PEX5 and a PEX5 protein 
possessing a cysteine-to-lysine substitution yielded negative results [49]. However, whether or not 
the PIM was working at its maximum capacity in the assays used in that work remains unknown, 
and thus a putatively rate-limiting step (i.e., monoubiquitination of the lysine-containing PEX5) 
might have escaped detection. The fact that the thiol group of a cysteine residue is a good leaving 
group may also have an impact on the monoubiquitination/deubiquitination cycle of the receptors. 
Indeed, as discussed above, deubiquitination of these thioesters may be achieved simply by a non-
enzymatic trans-acylation reaction of the bound ubiquitin to a physiological relevant nucleophile 
(e.g., glutathione). As hypothesized before, the existence of redundant deubiquitination 
mechanisms acting on these receptors might increase their half-lives [49]. Finally, it may be 
relevant to note that modification of the conserved cysteine of the receptors by any molecule other 
than ubiquitin would immediately block the DTM. Considering that cysteine residues can be 
modified in several manners (e.g., oxidized, and acylated), the conserved cysteine could also have a 
regulatory role functioning, for instance, as a sensor of oxidative stress. In this putative scenario, 
newly synthesized peroxisomal enzymes (e.g., catalase) would no longer be imported into the 
organelle and would remain in the cytosol [49,95]. We are still far from understanding how the 
RING peroxins work, but problems with this family of proteins are clearly not unique to the 
peroxisome biogenesis field. Naturally, in vitro ubiquitination assays using recombinant proteins 
may provide some of the answers we need, particularly if the substrate-binding subunit(s) of the 
peroxisomal E3 is(are) included in the assays. The recent findings showing that all three RING 
peroxins are needed for both monoubiquitination and polyubiquitination of PEX20 [73] should also 
be considered when performing this type of in vitro assays, because they raise the so-far 
unexpected possibility that the RING peroxins work, not alone, not in pairs, but rather as a trio of 
modules of a multi-Zn
2+
-binding domain E3 ligase. Clearly, there is still a long way to go before we 
understand the molecular details of receptor ubiquitination at the DTM. 
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Table 1: The Peroxisomal Import Machinery (PIM). Peroxisomal protein import components are 
organized into functional/structural units. Their subcellular localization and key features, as well as 
their distribution among different organisms are indicated. M, mammals; P, plants; Y, yeast; F, 
fungi; IDD, intrinsically disordered domain; TPRs, tetratricopeptide repeats; SH3, Src homology 3 
domain; RING, really interesting new gene; AAA, ATPases associated with diverse cellular activities. 
# PEX1.PEX6-membrane anchor: PEX26 (M, Y, F), APEM9 (P), or PEX15 (Y). PEX8 [30]; PEX17 [96]; 
PEX14/17 [97]; PEX33 [98]. 
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Fig. 1. The roles of ubiquitin in the peroxisome protein import machinery. Peroxisomal matrix cargo 
proteins (CP) are recognized by cycling receptors (R) in the cytosol. These receptor·cargo protein 
complexes dock at the peroxisomal membrane docking/translocation module (DTM) (arrow A). The 
strong protein–protein interactions established between the receptor and DTM components result 
in the insertion of the receptor into the DTM with the concomitant translocation and release of the 
cargo protein into the organelle matrix (arrow B). The receptor is then monoubiquitinated at a 
conserved cysteine residue (arrow C), and extracted back to the cytosol by the ATP-dependent 
receptor export module (REM) (arrow D). Finally, the ubiquitin moiety is removed probably by a 
combination of enzymatic (DUBs) and non-enzymatic mechanisms (e.g., by nucleophiles such as 
glutathione, GSH) (arrow E). When receptors become jammed at the DTM, they are removed and 
degraded via the ubiquitin-proteasome pathway (UPS). 
